viernes, 4 de enero de 2019

Microbiome startup Vedanta eyes large-scale clinical trials - STAT

Microbiome startup Vedanta eyes large-scale clinical trials - STAT

Daily Recap

STAT Plus: Startup Spotlight: Vedanta Biosciences eyes large-scale clinical trials for microbiome drugs

By KATE SHERIDAN


ALEX HOGAN/STAT
With a $27 million Christmas gift, Vedanta Biosciences plans to take its decidedly different approach to bacteria-based drugs to the clinic.

No hay comentarios: